Kristina Aleksandrova Todorova, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Aging | 1 | 2020 | 127 | 0.650 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 278 | 0.550 |
Why?
|
| Y-Box-Binding Protein 1 | 2 | 2021 | 40 | 0.360 |
Why?
|
| Skin Neoplasms | 4 | 2021 | 5686 | 0.250 |
Why?
|
| Ultraviolet Rays | 3 | 2020 | 1060 | 0.240 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 528 | 0.160 |
Why?
|
| Cosmetic Techniques | 1 | 2020 | 135 | 0.160 |
Why?
|
| Administration, Cutaneous | 1 | 2020 | 711 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13695 | 0.140 |
Why?
|
| Keratinocytes | 2 | 2018 | 798 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 987 | 0.130 |
Why?
|
| Keratosis, Seborrheic | 1 | 2015 | 27 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2015 | 105 | 0.130 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 436 | 0.130 |
Why?
|
| Interferons | 2 | 2008 | 706 | 0.120 |
Why?
|
| Skin Diseases | 2 | 2021 | 1065 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 293 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 502 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2015 | 4034 | 0.080 |
Why?
|
| DNA Repair | 2 | 2008 | 2046 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2219 | 0.080 |
Why?
|
| Cell Survival | 2 | 2015 | 5882 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2503 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3647 | 0.070 |
Why?
|
| Skin | 1 | 2020 | 4364 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 3523 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 2942 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 697 | 0.060 |
Why?
|
| Stem Cells | 1 | 2018 | 3567 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2003 | 3206 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 1526 | 0.050 |
Why?
|
| Transfection | 2 | 2008 | 5892 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8664 | 0.050 |
Why?
|
| Proteome | 1 | 2010 | 1799 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2010 | 1583 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 1758 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 1889 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2021 | 690 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2018 | 101 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12208 | 0.040 |
Why?
|
| DNA Damage | 1 | 2008 | 2432 | 0.040 |
Why?
|
| Camptothecin | 1 | 2021 | 576 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 491 | 0.040 |
Why?
|
| Proteomics | 1 | 2010 | 3638 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 29786 | 0.040 |
Why?
|
| HeLa Cells | 3 | 2008 | 3128 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 513 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2018 | 690 | 0.030 |
Why?
|
| Epidermis | 1 | 2018 | 528 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2021 | 2234 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10481 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6314 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3557 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2015 | 19229 | 0.030 |
Why?
|
| Apoptosis | 2 | 2021 | 9727 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 443 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 1701 | 0.030 |
Why?
|
| Plasmids | 2 | 2008 | 2307 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2010 | 84 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.020 |
Why?
|
| Humans | 12 | 2021 | 744343 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2010 | 467 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2018 | 2967 | 0.020 |
Why?
|
| Nitric Oxide | 2 | 2008 | 2132 | 0.020 |
Why?
|
| Mice | 4 | 2021 | 81183 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2010 | 406 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11483 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3505 | 0.020 |
Why?
|
| Comet Assay | 1 | 2008 | 71 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 10638 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1801 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4186 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 976 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9386 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1184 | 0.020 |
Why?
|
| Amino Acids | 1 | 2010 | 1736 | 0.020 |
Why?
|
| Animals | 4 | 2021 | 168757 | 0.010 |
Why?
|
| Myeloid Cells | 1 | 2008 | 810 | 0.010 |
Why?
|
| Buffers | 1 | 2003 | 147 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 6622 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2203 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2003 | 237 | 0.010 |
Why?
|
| Drug Stability | 1 | 2003 | 291 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11366 | 0.010 |
Why?
|
| Solubility | 1 | 2003 | 1085 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29063 | 0.010 |
Why?
|
| Escherichia coli | 2 | 2003 | 4217 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 689 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 1266 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2892 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2003 | 1526 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 3129 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 4320 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2008 | 3690 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3846 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2008 | 2020 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4568 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 7799 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14722 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15997 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 19905 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 5535 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 12797 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13815 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2003 | 2987 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 18111 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18029 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16689 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13033 | 0.000 |
Why?
|
| Female | 2 | 2014 | 380194 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 20822 | 0.000 |
Why?
|